VNPs displayed significant antimicrobial and biofilm disruption activity against C. albicans and strong anticancer potential against T3M-4 and CD18/HPAF pancreatic cancer cell lines, with IC50 ∼ 4 μg mL−1. Here, ITGB2 is linked to pancreatic neoplasm.